Overview
Argenx is a clinical-stage biopharmaceutical company that is creating and developing a pipeline of differentiated antibody therapeutics. Our unique antibody engineering technologies combined with the complementary expertise of our people enable us to build a clinical-stage portfolio of novel product candidates – tailored from discovery through development to address patient needs.